Skip to main content

Table 3 9cRA inhibits MNU-induced prostate carcinogenesis in p27 deficient mice

From: p27Kip1deficiency promotes prostate carcinogenesis but does not affect the efficacy of retinoids in suppressing the neoplastic process

   

PIN

P

Tumors

Genotype

Animals No

9cRA

Incidence

Frequency

 

P

DO

p27+/+

18

0

11

0.16 ± 0.5

 

0

0

p27+/+

17

+

0

0

0

0

0

p27+/-

16

0

60

1.5 ± 0.5*

 

3

4

p27+/-

15

+

44

1.1 ± 0.6

0.05

2

4

p27-/-

15

0

70

2.0 ± 0.4*

 

3

6

p27-/-

15

+

53

1.4 ± 0.5

0.005

4

6

  1. Animals were treated with MNU, 30 mg/kg body weight at the age of 2 months and followed until sacrifice between 7-12 months of age. PIN were identified in DLP by cutting longitudinally through the urethral part of the prostate. H&E staining was used for identification of PIN. Stepwise, 4 μm thick paraffin sections at three separate tissue levels 30 μm apart were cut and the number of PIN per prostate determined. Incidence, percentage of animals with PIN per group; frequency, number of PIN per animal. PIN were determined in various groups without knowledge of the treatment protocol. (P), prostate; (DO), distant organs; *, significant difference (p < 0.01) in the multiplicity of PIN between p27+/- and p27-/- mice;